| Sources | Names Used |
|---|---|
| CCLE, GDSC1000, GRAY | 17-AAG |
| FIMM | Tanespimycin |
| CTRPv2 | tanespimycin |
| PharmacoGx | 17-AAG |
| Database | Identifier |
|---|---|
| Smiles: | CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)C)OC)OC(=O)N)C)C)O)OC |
| Inchikey: | AYUNIORJHRXIBJ-TXHRRWQRSA-N |
| Pubchem: | 6505803 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NME3 | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | TMEM119 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | N4BP2 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | CDIP1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | BDKRB1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | MMAB | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | CPVL | CCLE | pan-cancer | AAC | -0.18 | 0.0001 |
| mRNA | RXRA | CCLE | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | ATP2B3 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | C1orf109 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
